Details for New Drug Application (NDA): 020529
✉ Email this page to a colleague
The generic ingredient in CONDYLOX is podofilox. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the podofilox profile page.
Pharmacology for NDA: 020529
Physiological Effect | Decreased Mitosis |
Suppliers and Packaging for NDA: 020529
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CONDYLOX | podofilox | GEL;TOPICAL | 020529 | NDA | Allergan, Inc. | 0023-6118 | 0023-6118-03 | 3.5 g in 1 TUBE, WITH APPLICATOR (0023-6118-03) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TOPICAL | Strength | 0.5% | ||||
Approval Date: | Mar 13, 1997 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020529
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | CONDYLOX | podofilox | GEL;TOPICAL | 020529-001 | Mar 13, 1997 | ⤷ Subscribe | ⤷ Subscribe |
Allergan | CONDYLOX | podofilox | GEL;TOPICAL | 020529-001 | Mar 13, 1997 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription